Cite
HARVARD Citation
William Hanke, C. et al. (2013). A Randomized, Placebo‐Controlled, Double‐Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint. Dermatologic surgery. 39 (6), pp. 891-899. [Online].